Molecular detection/diagnosis reagent for tumor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 29, 2020
Grant Date -
Jan 10, 2019
app pub date -
Dec 13, 2016
filing date -
Dec 31, 2015
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention discloses a tumor molecular detection/diagnostic reagent, which takes excrement as a detection sample and includes an SDC2 gene methylation detection reagent. The methylation level of the SDC2 gene detected in the excrement has an extremely high relevance to the onset of the colorectal cancer. The sensitivity of the SDC2 gene in the excrement is 87 percent and the specificity is up to 98 percent or even higher than that in tissue.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully